Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction: The Hygia Chronotherapy Trial
The progressive decrease in the asleep SBP mean during the 6.3 years of follow-up was the most significant predictor of reduced CVD risk.
The progressive decrease in the asleep SBP mean during the 6.3 years of follow-up was the most significant predictor of reduced CVD risk.
Atherosclerosis (ATH) and ATH-related diseases represent the leading cause of disability and mortality in the Western world.
Atrial Fibrillation is associated with increased comorbidity, such as stroke or heart failure, a 2-fold increase of mortality in both men and women and around 3% in anticoagulated AF patients.
The prevalence of Heart Failure increases with age and is over nine-fold higher among those 65 years or older compared to younger age groups.
India is experiencing epidemiologic transition with a sharp increase in coronary heart disease (CHD).
It is estimated that nearly 1.5 billion adults in the world will have hypertension in the decade ahead.